First Personal Financial Services’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

First Personal Financial Services’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-167	Closed	-$8K	–	967
2018 Q1	$8K	Sell	167 -112	-40%	-$4.1K	﹤0.01%	848
2017 Q4	$10K	Sell	279 -159	-36%	-$6.94K	﹤0.01%	788
2017 Q3	$23K	Hold	438	–	–	﹤0.01%	566
2017 Q2	$25K	Buy	438 +158	+56%	+$7.93K	0.01%	545
2017 Q1	$15K	Hold	280	–	–	﹤0.01%	629
2016 Q4	$16K	Buy	+280	New	+$16.9K	﹤0.01%	599

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

First Personal Financial Services's KDNY Position: Q2 2018 in Review

First Personal Financial Services sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2018, closing a stake of 167 shares — an estimated $8K sold.

First Personal Financial Services first reported a position in KDNY in Q4 2016 and held it in 6 quarters. The position peaked at $25K in Q2 2017. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2018.

First Personal Financial Services reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
First Personal Financial Services sold 167 Chinook Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $8K.
First Personal Financial Services first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
First Personal Financial Services's Chinook Therapeutics, Inc. Common Stock position peaked at $25K in Q2 2017.
89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.